Barclays’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-124,100
Closed -$2.11M – 5483
2025
Q4
$2.11M Buy
+124,100
New +$1.26M ﹤0.01% 2893

Other funds holding WVE

Barclays's WVE Position: Q3 2026 in Review

Barclays sold out of Wave Life Sciences (WVE) in Q3 2026, closing a stake of 309,580 shares — an estimated $1.8M sold.

Barclays first reported a position in WVE in Q2 2016 and held it in 39 quarters. The position peaked at $4.71M in Q4 2025. 211 funds tracked by Wall St. Rank hold WVE as of Q3 2026.

  • Barclays reported no remaining Wave Life Sciences position as of Q3 2026 after selling out during the quarter.
  • Barclays sold 309,580 Wave Life Sciences shares in Q3 2026, an estimated $1.8M.
  • Barclays first reported a position in Wave Life Sciences in Q2 2016 and held it in 39 quarters.
  • Barclays's Wave Life Sciences position peaked at $4.71M in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.